Noxopharm hails new Sofra™ drug inflammation results

Noxopharm Ltd (ASX:NOX, OTC:NOXOF) CEO Dr Gisela Mautner tells Proactive a new pre-clinical product candidate from its Sofra™ technology platform, known as...

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , Gisela Mautner , Melbourne Hudson Institute Of Medical Research , International Congress On Systemic Lupus Erythematosus , Noxopharm Ltd , Hudson Institute , Medical Research , International Congress , Systemic Lupus Erythematosus ,